DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Dr. Allison King on Sickle Cell Disease and Learning
Excerpts from our conversation with Dr. Allison King, an NIH-funded sickle cell specialist at Washington University in St. Louis.
NIHNiH: People with sickle cell disease – even children – have a higher than normal risk of stroke. What other challenges can sickle cell disease pose to the developing brain?
King: Both overt and silent strokes can harm the brain. But we’ve also realized that there are some children who haven’t had a stroke who also have a lot of trouble in school. Now we know that things like lower oxygen levels in the blood can also be associated with cognitive challenges. It’s also very stressful on the central nervous system to be chronically anemic. Plus, the inflammation from the disease can be a challenge to the brain as well.
+myBinderRelated Content
-
news & eventsCurrent Advocacy Work in Sickle Cell Disease: The Global PerspectiveJoin the Global Alliance of Sickle Cell ...
-
people & placesSuzanne Saccente, MDDr. Suzanne Saccente received her medica...
-
videos & visualsVaso occlusive Crisis Pain Assessment & Managementhttps://www.youtube.com/watch?time_conti...
-
education & researchPsychosocial and Clinical Risk Factors Associated With Substance use in Observational Cohort of Patients With Sickle...Patients with sickle cell disease (SCD) ...
-
people & placesShelley Crary, MD, MSDr. Shelley Crary received her undergrad...
-
news & eventsGlobal Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
education & researchBlood transfusions for treating acute chest syndrome in people with sickle cell diseaseBackground: Sickle cell disease is an...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.